Accéder au contenu
Merck

PHR1285

Lovastatin

Pharmaceutical Secondary Standard; Certified Reference Material

Synonyme(s) :

Lovastatin, Mevinolin

Se connecter pour consulter les tarifs organisationnels et contractuels.

Sélectionner une taille de conditionnement


A propos de cet article

Formule empirique (notation de Hill) :
C24H36O5
Numéro CAS:
Poids moléculaire :
404.54
UNSPSC Code:
41116107
NACRES:
NA.24
Service technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aider
Service technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aider

Nom du produit

Lovastatin, Pharmaceutical Secondary Standard; Certified Reference Material

SMILES string

O1[C@@H](C[C@H](CC1=O)O)CC[C@@H]2[C@H]3[C@H](C[C@H](C=C3C=C[C@@H]2C)C)OC(=O)[C@H](CC)C

InChI

1S/C24H36O5/c1-5-15(3)24(27)29-21-11-14(2)10-17-7-6-16(4)20(23(17)21)9-8-19-12-18(25)13-22(26)28-19/h6-7,10,14-16,18-21,23,25H,5,8-9,11-13H2,1-4H3/t14-,15-,16-,18+,19+,20-,21-,23-/m0/s1

InChI key

PCZOHLXUXFIOCF-BXMDZJJMSA-N

grade

certified reference material
pharmaceutical secondary standard

agency

traceable to Ph. Eur. L0790000
traceable to USP 1370600

API family

lovastatin

CofA

current certificate can be downloaded

technique(s)

HPLC: suitable
gas chromatography (GC): suitable

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

-10 to -25°C

Quality Level

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Analysis Note

These secondary standards offer multi-traceability to the US and EP primary standards, where they are available.

Application

Lovastatin may find its use as a pharmaceutical reference standard for the determination of the analyte in pharmaceutical formulations by spectrophotometric, thermal characterization, and chromatographic techniques.
These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.

General description

Lovastatin, an orally administered drug, is a lactone metabolite used for the treatment of hypercholesterolemia and coronary heart diseases. It is a hexahydronaphtalene drug, belonging to the class of HMG-CoA (3-hydroxy-3-methyl-glutaryl-coenzyme A) reductase inhibitors.
Pharmaceutical secondary standard for application in quality control. Provides pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.

Other Notes

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
To see an example of a Certificate of Analysis for this material enter LRAC3329 in the slot below. This is an example certificate only and may not be the lot that you receive.

pictograms

Health hazard

signalword

Warning

Hazard Classifications

Carc. 2 - Repr. 2

Classe de stockage

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable


Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Instrumental analysis of potential lovastatin-Excipient interactions in preformulation studies
Ledeti I, et al.
Revista de Chimie (Bucharest, Romania), 66(22), 879-882 (2015)
Thermal characterization of lovastatin in pharmaceutical formulations
Yoshida MI, et al.
Journal of Thermal Analysis and Calorimetry, 106(3), 657-664 (2011)
Two derivative spectrophotometric methods for the simultaneous determination of lovastatin combined with three antioxidants
Markopoulou CK and Koundourelllis JE
Journal of Pharmaceutical and Biomedical Analysis, 33(5), 1163-1173 (2003)
Lovastatin decreases coenzyme Q levels in humans.
Folkers K, et al.
Proceedings of the National Academy of Sciences of the USA, 87(22), 8931-8934 (1990)
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS
Downs JR, et al.
JAMA : The Journal of the American Medical Association, 279(20), 1615-1622 (1998)

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique